Unknown Author
January 24, 2026
Kirkland Advises Brookfield and Everise on Investment in Everise by Warburg Pincus

1 min
AI-made summary
- Kirkland & Ellis represented Everise, a global healthcare services outsourcing company, and its investor Brookfield in an investment by Warburg Pincus
- The investment values Everise at approximately $1 billion
- Brookfield and Warburg Pincus plan to support Everise's growth through business expansion and mergers and acquisitions
- The transaction is subject to customary regulatory approvals and is expected to close by the end of 2023.
Kirkland & Ellis advised Everise, a leading global healthcare services outsourcing company, and its existing investor, Brookfield, in connection with an investment in Everise by Warburg Pincus. Brookfield and Warburg Pincus are committed to accelerating the growth trajectory of Everise through business expansion and M&A. Warburg Pincus’ investment values the company at around $1 billion. The transaction is subject to customary regulatory approvals and is expected to close by the end of 2023. Read the transaction press release The Kirkland team was led by corporate partners Srinivas Kaushik and Adam Clifford, with support from partners Kartik Khanna and Adarsh Varghese; debt finance partners Mary Kogut and Melissa Hutson; tax partners Sara Zablotney and Adam Arikat; and executive compensation partners Scott Price and John Kleinjan.
Article Author
Unknown Author
The Sponsor
